Argonaut Therapeutics
Mr Dixon-Clegg is Principal Investor at Oxford Sciences Innovation (OSI). He previously held investment roles at Bank of America Merrill Lynch, Nordic Capital and Valiance Asset Management, specialising in healthcare and life sciences companies. He holds an MA in Natural Sciences (Triple First) from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Argonaut Therapeutics
Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal.